Navigation Links
Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
Date:10/8/2008

n women than in men(4).

The exact process by which PAH develops is not known. However, it appears to be associated with a variety of disease processes, including chronic thromboembolic disease (blood clots), connective tissue diseases, congenital heart disease and exposure to external factors including appetite suppressants or infectious diseases such as HIV(3).

1. Novartis has also conducted early stage research with imatinib mesylate

in another non-oncology disease called idiopathic pulmonary fibrosis

(IPF), a condition in which the lungs become scarred over time, making it

more and more difficult to breathe(6). Early clinical trial results in

IPF did not show a significant treatment benefit over placebo, and

clinical trials have therefore been halted.

About Gleevec

Gleevec(R) (imatinib mesylate) tablets are indicated for the treatment of newly diagnosed adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase. Follow-up is limited to 5 years. Gleevec is also indicated for the treatment of patients with Ph+ CML in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha (IFN-alpha) therapy; adult patients with relapsed or refractory Ph+ acute lymphoblastic leukemia (Ph+ ALL); adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor) gene rearrangements; adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-KIT mutation or with c-KIT mutational status unknown; adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the FIP1L1-PDGFRa fusion kinase (mutational analysis or FISH demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1-PDGFRa fusion kinase-negative or unknown; adult patients with unresectable, re
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test
2. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
3. Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
4. New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)
5. Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium
6. K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers Grains
7. Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimers
8. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
9. Eight-Year Melanoma Remission is Among Early Cancer Treatment Results
10. Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients Day
11. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...  Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... t:slim® and t:flex™ Insulin Pumps, today announced the pricing ... its common stock at a price to the public ... from this offering are expected to be $56.3 million, ... offering expenses payable by Tandem. All of the shares ...
(Date:2/26/2015)... BEND, Ind. , Feb. 26, 2015  Mobility ... announce an agreement with Bank of America (NYSE: ... consumers nationwide to receive financing of the revolutionary MV-1 ... vehicle, designed from the ground up to provide safe ... Approved applicants can use their loan to purchase a ...
(Date:2/26/2015)... DALLAS , February 26, 2015 ... EU Outlook 2015: First -In- Class Innovations and ... Business for Large Cap Pharmaceutical Companies research report ... According to this Global Pharma US ... divested as productivity measurements, divestment of non-core assets ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4
... 28, 2012   OncoSec Medical Incorporated (OTCBB: ONCS), ... ElectroOncology therapies to treat solid tumor cancers, today announced ... by the University of California San Francisco and the ... clinical trial evaluating OncoSec,s OMS ElectroImmunotherapy for ...
... from visual impairment due to autism, brain injury, stroke or ... a revolutionary new therapy program using specially designed games and ... Therapy Program uses a web-based application in which patients ... system dysfunction and strengthen visual skills. The application was created ...
Cached Medicine Technology:OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 2OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 3OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 4New Therapy Program Allows Doctors to Prescribe Computer Games on iPad to Treat Visual Impairment 2
(Date:2/27/2015)... 27, 2015 Prescription Drug “Take-Back” ... Drug Enforcement Agency (DEA). Today, local ... to utilize the “Take-Back” guidelines for the proper ... , Eufaula Prescription Drug Disposal Event , The ... in Eufaula, Oklahoma as the “Take-Back” site for ...
(Date:2/27/2015)... a Feb. 12, 2015 news release by Verastem, Inc. ... killing cancer stem cells, has received orphan drug designation from ... the treatment of mesothelioma.* According to the release, orphan drug ... of drugs for the treatment of rare diseases. , ... Helbock, Founder of The Law Office of Melinda J. Helbock ...
(Date:2/27/2015)... Albany, NewYork (PRWEB) February 27, 2015 ... opportunities, and trends in the global celiac disease market. ... financial outlook, research and development activities, and investments. , ... indigestion of gluten damages the small intestine. Celiac disease ... one in every 100 people is affected by celiac ...
(Date:2/27/2015)... MA (PRWEB) February 27, 2015 A fireplace ... 20 percent of its heat through the chimney’s flue when ... energy issue that Tamarack Technologies has solved with the introduction ... is actually a PVC pillow measuring 18" in diameter when ... or zero-clearance fireplace just below the damper. This size unit ...
(Date:2/27/2015)... 2015 According to the Center ... 38 million children and adolescents participate in sports ... a result of this growing number, new and ... and square footage creating a need for preventative ... , "Athletic facilities are hosting a record ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 3Health News:New DraftStopper from Tamarack Technologies Stops Heat Loss When Fireplace Not in Use 2Health News:Rise of Students Participating in Sports Creates Need for Preventative Maintenance to Gymnasium Equipment in Athletic Facilities 2Health News:Rise of Students Participating in Sports Creates Need for Preventative Maintenance to Gymnasium Equipment in Athletic Facilities 3
... Fox Chase Cancer Center have demonstrated that a protein called ... forms of breast cancer to grow. Their findings, based on ... presented in a recent issue of Cancer Research , ... been able to present evidence that directly demonstrates reduced levels ...
... side effects, say UK researchers, , FRIDAY, Oct. 2 ... does not increase the risk for self-harm or depression, ... the U.S. Food and Drug Administration mandated that the ... that people who use it face increased risk for ...
... ... , ... 2009 -- Finding information to provide essential and practical aid and care during serious situations ... may not be able to deliver a timely response, or to administer self-care without a ...
... Hickman, United Feather & Down,s Senior Vice Present of Sales ... of Marketing, list their top sleep and beauty tips. , ... than water, and its super emollient qualities help it moisturize ... to your skin to help you awaken refreshed and rejuvenated. ...
... , DALLAS, Oct. 2 Ben DuBose, of DuBose Law Firm, PLLC, ... Texas Monthly as one of the select "Texas Super Lawyers" in ... this year, Mr. DuBose was chosen as one of the "Best Lawyers ... by Law & Politics Media and Texas Monthly ...
... SUMMIT, Mo., Oct. 2 R&D/Leverage,s enhanced medical and ... roof - continue to expand in anticipation of further ... President - Engineering. , According to Wescoat, the company,s ... staff, new lean initiatives and quality-control protocols and world-class ...
Cached Medicine News:Health News:NEDD9 protein supports growth of aggressive breast cancer 2Health News:Study Counters Warnings on Quit-Smoking Drug 2Health News:VisionSync Launches a Smart iPhone First Aid App, iMobile Care 2Health News:VisionSync Launches a Smart iPhone First Aid App, iMobile Care 3Health News:Ten from Two: Top Sleep and Beauty Tips from the Experts 2Health News:Ten from Two: Top Sleep and Beauty Tips from the Experts 3Health News:'Texas Monthly' Recognizes Ben DuBose Among the Super Lawyers of Texas 2Health News:R&D/Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 2Health News:R&D/Leverage Heightens Investment in Medical and Silicone Mold Manufacturing 3
... Are Available In Two Models: One Is Direct ... Jaws Close. The Other Model Is Reverse ... Compressed The Jaws Open., ,The Forceps Are 22g, ... Through A 1.1mm Incision. These Forceps Allow The ...
... Allows Use Through A 1-Millimeter Incision.,Special ... Approach To The Incision.,Cystotome Tips Are ... Initiate And Complete A Circular Tear.,Titanium ... Improved Ergonomic Feel. Ideal For Bi-Manual ...
... fiber optic for homogenous illumination. ... bright halogen illumination for clear ... canal. Lithium-ion batteries with ... rheostat for fine control of ...
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
Medicine Products: